Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses

Interleukin-10 (IL-10) is a dimeric cytokine with both immunosuppressive and immunostimulatory activities; however, IL-10-based therapies have shown only marginal clinical benefits. Here, we explored whether the stability of the IL-10-receptor complex contributes to the immunomodulatory potency of I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Signal
Main Authors: Gorby, Claire, Bellón, Junel Sotolongo, Wilmes, Stephan, Warda, Walid, Pohler, Elizabeth, Fyfe, Paul K., Cozzani, Adeline, Ferrand, Christophe, Walter, Mark R., Mitra, Suman, Piehler, Jacob, Moraga, Ignacio
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7685028/
https://ncbi.nlm.nih.gov/pubmed/32934073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.abc0653
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados